3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
19
Phase 2
16
Phase 3
10
Phase 1/2
5
Phase 2/3
4
Sponsor
Interventions
pembrolizumab
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Radiotherapy
2
Ipilimumab
2
Fluorodeoxyglucose F18
2
Cyclophosphamide
2
sugemalimab
1
semaglutide
1
sacituzumab govitecan
1
prednylidene
1
pirtobrutinib
1
paricalcitol
1
mirdametinib
1
gadobutrol
1
fludarabine phosphate
1
fludarabine
1
erdafitinib
1
enfortumab vedotin
1
deltacortene
1
daratumumab
1
brivaracetam
1
brexucabtagene autoleucel
1
azeliragon
1
avelumab
1
alovudine
1
acalabrutinib
1
Watchful Waiting
1
Vorinostat
1
Vincristine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Cetuximab
×
30 days
×
Clear all
No trials found.